J. B. Posner

7.2k total citations · 1 hit paper
65 papers, 5.3k citations indexed

About

J. B. Posner is a scholar working on Neurology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, J. B. Posner has authored 65 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 12 papers in Genetics. Recurrent topics in J. B. Posner's work include Autoimmune Neurological Disorders and Treatments (26 papers), Glioma Diagnosis and Treatment (11 papers) and Genetic Neurodegenerative Diseases (10 papers). J. B. Posner is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (26 papers), Glioma Diagnosis and Treatment (11 papers) and Genetic Neurodegenerative Diseases (10 papers). J. B. Posner collaborates with scholars based in United States, United Kingdom and Spain. J. B. Posner's co-authors include F. Plum, Norman L. Chernik, Josep Dalmau, Marc K. Rosenblum, Henry Furneaux, Francesc Graus, Carlos Cordon‐Cardo, Marcus E. Raichle, George Krol and Joseph H. Galicich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

J. B. Posner

64 papers receiving 5.0k citations

Hit Papers

Intracranial metastases from systemic cancer. 1978 2026 1994 2010 1978 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. B. Posner United States 36 2.7k 1.3k 1.1k 995 918 65 5.3k
Junkoh Yamashita Japan 44 1.7k 0.6× 813 0.6× 1.2k 1.1× 734 0.7× 1.8k 1.9× 245 6.7k
Masashi Fukui Japan 45 3.4k 1.2× 1.0k 0.8× 1.3k 1.1× 1.1k 1.1× 780 0.8× 296 7.3k
Yoichi Nakazato Japan 42 1.5k 0.6× 991 0.8× 2.1k 1.9× 995 1.0× 2.4k 2.6× 258 6.8k
Michael S. B. Edwards United States 46 2.2k 0.8× 1.2k 1.0× 2.9k 2.6× 1.2k 1.3× 1.7k 1.8× 174 7.7k
Akira Yamaura Japan 39 3.1k 1.1× 1.0k 0.8× 677 0.6× 578 0.6× 635 0.7× 257 5.5k
Jacques Brotchi Belgium 47 2.4k 0.9× 1.1k 0.8× 2.3k 2.1× 1.1k 1.1× 1.2k 1.4× 256 7.3k
Norihiko Tamaki Japan 34 1.9k 0.7× 609 0.5× 488 0.4× 875 0.9× 635 0.7× 249 4.7k
Anthony T. Yachnis United States 46 1.7k 0.6× 541 0.4× 1.7k 1.5× 1.0k 1.1× 2.4k 2.6× 143 6.4k
Liliana Goumnerova United States 45 1.6k 0.6× 772 0.6× 2.5k 2.2× 889 0.9× 1.7k 1.9× 122 5.8k
Tadanori Tomita United States 43 1.3k 0.5× 638 0.5× 1.9k 1.7× 1.1k 1.2× 1.5k 1.6× 217 5.9k

Countries citing papers authored by J. B. Posner

Since Specialization
Citations

This map shows the geographic impact of J. B. Posner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. B. Posner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. B. Posner more than expected).

Fields of papers citing papers by J. B. Posner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. B. Posner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. B. Posner. The network helps show where J. B. Posner may publish in the future.

Co-authorship network of co-authors of J. B. Posner

This figure shows the co-authorship network connecting the top 25 collaborators of J. B. Posner. A scholar is included among the top collaborators of J. B. Posner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. B. Posner. J. B. Posner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Posner, J. B., et al.. (2019). Monoclonal Antibodies: Past, Present and Future. Handbook of experimental pharmacology. 260. 81–141. 54 indexed citations
2.
Posner, J. B. & Josep Dalmau. (2000). Paraneoplastic Syndromes of the Nervous System. Clinical Chemistry and Laboratory Medicine (CCLM). 38(2). 117–122. 27 indexed citations
3.
Verschuuren, Jan J.G.M., et al.. (1998). Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis. Journal of Neuroimmunology. 82(2). 200–209. 31 indexed citations
4.
Ross, Ronald, Darina L. Lazarova, Geoffrey T. Manley, et al.. (1997). HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells. European Journal of Cancer. 33(12). 2071–2074. 28 indexed citations
5.
Rosenfeld, Myrna R., Laura Schramm, J. B. Posner, et al.. (1997). Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 89(5). 381–384. 45 indexed citations
6.
Forsyth, Peter, Josep Dalmau, Francesc Graus, et al.. (1997). Motor neuron syndromes in cancer patients. Annals of Neurology. 41(6). 722–730. 123 indexed citations
7.
Graus, Francesc, R. Reñé, Núria Malats, et al.. (1997). Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.. Journal of Clinical Oncology. 15(8). 2866–2872. 300 indexed citations
8.
Smitt, Peter Sillevis, Geoffrey T. Manley, Josep Dalmau, & J. B. Posner. (1996). The HuD paraneoplastic protein shares immunogenic regions between PEM/PSN patients and several strains and species of experimental animals. Journal of Neuroimmunology. 71(1-2). 199–206. 10 indexed citations
9.
Muresu, Rosella, Antonio Baldini, Thomas M. Gress, et al.. (1994). Mapping of the gene coding for a paraneoplastic encephalomyelitis antigen (HuD) to human chromosome site 1p34. Cytogenetic and Genome Research. 65(3). 177–178. 16 indexed citations
10.
Manley, Geoffrey A., Edmund Wong, Josep Dalmau, et al.. (1994). Sera from some patients with antibody-associated paraneoplastic encephalomyelitis/sensory neuronopathy recognize the Ro-52K antigen. Journal of Neuro-Oncology. 19(2). 105–112. 12 indexed citations
11.
Posner, J. B.. (1994). The Anti-Hu Syndrome: A Model Paraneoplastic Disorder. Recent results in cancer research. 135. 77–90. 8 indexed citations
12.
Cordon‐Cardo, Carlos, et al.. (1992). P-glycoprotein expression in brain tumors. Journal of Neuro-Oncology. 14(1). 37–43. 74 indexed citations
13.
Gress, Thomas M., Antonio Baldini, Mariano Rocchi, et al.. (1992). In situ mapping of the gene coding for a leucine zipper DNA binding protein (CDR62) to 16p12–16p13.1. Genomics. 13(4). 1340–1342. 4 indexed citations
14.
Posner, J. B.. (1992). Pathogenesis of central nervous system paraneoplastic syndromes.. PubMed. 148(6-7). 502–12. 24 indexed citations
15.
Chen, Yu, W J Rettig, Aswani Yenamandra, et al.. (1990). Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse.. Proceedings of the National Academy of Sciences. 87(8). 3077–3081. 54 indexed citations
16.
Kim, Jae Ho, et al.. (1989). The combined use of radiation therapy and lonidamine in the treatment of brain metastases. Journal of Neuro-Oncology. 7(3). 241–7. 66 indexed citations
17.
Anderson, Neil E., J. B. Posner, John J. Sidtis, et al.. (1988). The metabolic anatomy of paraneoplastic cerebellar degeneration. Annals of Neurology. 23(6). 533–540. 32 indexed citations
18.
Posner, J. B. & William R. Shapiro. (1975). Brain Tumor. Archives of Neurology. 32(12). 781–781. 39 indexed citations
19.
Gazzaniga, Michael S., et al.. (1973). Pure Word Deafness and Hemispheric Dynamics a Case History. Cortex. 9(1). 136–143. 49 indexed citations
20.
Posner, J. B. & F. Plum. (1967). Independence of Blood and Cerebrospinal Fluid Lactate. Archives of Neurology. 16(5). 492–496. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026